Introduction
Programmed cell death (apoptosis) can be triggered by a variety of stimuli via two principal signaling pathways, both of which depend on the formation of multimeric protein complexes and subsequent activation of death proteases, called caspases (Cryns and Yuan, 1998; Thornberry and Lazebnik, 1998) . The extrinsic death pathway involves the ligation of death receptors (Fas/CD95; tumor necrosis factor receptor I/CD 120a) that leads to the recruitment of the adaptor molecule Fas-associated death domain and pro-caspase-8 into a death-inducing signaling complex (DISC) (Kischkel et al., 1995; Muzio et al., 1996) . The intrinsic death pathway is initiated at the mitochondrion by the release of cytochrome c that together with dATP and Apaf-1 binds to pro-caspase-9 to form the apoptosome (Cryns and Yuan, 1998; Li et al., 1997b) . Upon formation of the DISC or the apoptosome, pro-caspases-8 or -9, respectively, are autoproteolytically processed resulting in the activation of downstream caspases such as caspases-3, -6 and -7 (Srinivasula et al., 1996; Slee et al., 1999) . Although both pathways are linked through the caspase-8-mediated cleavage of the pro-apoptotic Bcl-2-related protein Bid that triggers cytochrome c release, DNA-damaging agents are believed to mediate apoptosis via mitochondrial cytochrome c release independent of the death receptor pathway (Ferrari et al., 1998; Wesselborg et al., 1999; Belka et al., 1999) . The signals, however, leading to cytochrome c release are not understood.
Fourteen distinct mammalian caspases have been identi®ed that make a limited number of strategic cuts in a variety of key cellular proteins, resulting either in inhibition or deregulation of their function (Nicholson and Thornberry, 1997; Porter et al., 1997; Van de Craen et al., 1998) . Although these proteases can be placed into three groups on the basis of their in vitro substrate preferences (Nicholson and Thornberry, 1997; Talanian et al., 1997) , little is known of their in vivo substrate speci®cities. The majority of known caspase substrates are cleaved by caspase-3 or a related protease, including important proteins like gelsolin, protein kinase C-d, p21-activated kinase-2, a-fodrin, the retinoblastoma protein, and DNA fragmentation factor, whose proteolysis most likely contributes to apoptosis in various ways (Nicholson and Thornberry, 1997) .
Some tumor cells readily undergo apoptosis when exposed to ligands of the TNF 1 family (such as TNFa and CD95L), anticancer drugs or ionizing radiation (IR), while others do not; but the molecular basis of these dierences is poorly understood (Wertz and Hanley, 1996; Hannun, 1997; Ashkenazi and Dixit, 1998) . Many tumor cell lines harboring the casp-3 gene are resistant to TNF-induced apoptosis. In contrast, MCF-7 breast carcinoma cells, which have lost caspase-3 owing to a genomic deletion in the casp-3 gene, are still sensitive to TNF or staurosporine, demonstrating the existence of caspase-3-independent death pathway(s) induced by these agents (JaÈ nicke et al., 1998a,b) . However, caspase-3 is required for cell death resulting from microinjected cytochrome c (Li et al., 1997a) and for TNF-induced apoptotic DNA fragmentation and membrane blebbing (JaÈ nicke et al., 1998b) , which are classic hallmarks of apoptosis.
The cellular response to DNA damage includes the induction of apoptosis (Hannun, 1997; Fisher, 1994; Wang, 1998) , but the failure to respond properly to DNA damage can lead to genetic alterations that promote tumor progression. The tumor suppressor p53 plays a major role in modulating the apoptotic response following DNA damage that is either dependent or independent of its transcriptional activity (Ko and Prives, 1996; Levine, 1997) . Loss of p53 function is observed in over half of all human cancers (Hollstein et al., 1991) , and in many cases the susceptibility of tumor cells to anticancer drugs or IR depends on their p53 status (Clarke et al., 1993; Fan et al., 1994) . However, some tumor cells with functional p53 are relatively resistant to anticancer drugs or IR (Zhan et al., 1994; Fan et al., 1995) . MCF-7 belongs to such a class of tumor cell (Levenson and Jordan, 1997) , which harbors a wildtype p53 gene and is relatively resistant to p53-dependent apoptosis induced by DNA-damaging agents (Zhan et al., 1994; Fan et al., 1995) . We investigated more closely the role of caspase-3 in apoptosis induced by DNA-damaging agents, because caspases can act downstream of p53 (Sabbatini et al., 1997; Schuler et al., 2000) , and caspase-3-like proteases may play a role in DNA damage-induced apoptosis (Dubrez et al., 1996; Faleiro et al., 1997; Fuchs et al., 1997; Martins et al., 1997; Simizu et al., 1998; Yu and Little, 1998) .
In this study, we address the related questions of (i) whether caspase-3 is required for apoptosis induced by DNA-damaging agents; (ii) whether caspase-3 is essential for DNA fragmentation and speci®c cleavage of a-fodrin induced by DNA-damaging agents; and (iii) whether dierent DNA-damaging agents utilize the same apoptotic pathway leading to the activation of the intrinsic death pathway.
Results

Etoposide and doxorubicin, but not IR induce apoptosis in MCF-7 cells
Using the human MCF-7 breast carcinoma cell line that is devoid of caspase-3, we and others have previously demonstrated that caspase-3 is not essential for TNF-, Fas-or staurosporine-induced apoptotic cell death (JaÈ nicke et al., 1998a,b; Li et al., 1997a) . To investigate whether these caspase-3-de®cient cells may have acquired a selective growth advantage in the presence of DNA-damaging agents, MCF-7 cells were exposed to the anticancer drugs etoposide and doxorubicin or IR. As a control, caspase-3-expressing HeLa H21 cells were treated in a similar fashion. Etoposide (100 mM) or doxorubicin (1 mg/ml) treatment of HeLa and MCF-7 cells resulted in a time-dependent decrease of cell viability as measured with the standard crystal violet assay (JaÈ nicke et al., 1994; Figure 1a,b) . Similar results were obtained when cell death was assessed by the trypan blue exclusion test (data not shown). The rate of this decrease was slower in MCF-7 cells, which were slightly more resistant than HeLa cells to cell death induced by these agents 3 days after Figure 1 Etoposide or doxorubicin, but not IR induce apoptosis in caspase-3-de®cient MCF-7 cells. Cytotoxicity assays of HeLa H21 cells (circles) and MCF-7 cells (squares) treated for the indicated times with etoposide (100 mM) (a) or doxorubicin (1 mg/ ml) (b), or exposed to IR (20 Gy) (c) followed by incubation with growth medium. Cell death was assessed using the crystal violet assay as described (JaÈ nicke et al., 1994) . Similar results were obtained when cell death was assessed by trypan blue uptake (data not shown). The values are derived from one representative experiment of four performed in triplicates. (d) HeLa H21 cells (circles) and MCF-7 cells (squares) were exposed to the indicated radiation doses in the absence (open symbols) or presence (®lled symbols) of zVAD-fmk (50 mM). After 3 days, cell death was assessed by propidium iodide uptake and subsequent FACS analyses treatment (Figure 1 ). Anticancer drug-induced killing of both cell lines was inhibitable by the broad spectrum caspase inhibitor zVAD-fmk (data not shown) demonstrating that even MCF-7 cells lacking caspase-3 die via a caspase-dependent apoptotic pathway. This result is in agreement with our previous studies showing that TNF or staurosporine induce apoptosis in caspase-3-de®cient MCF-7 cells (JaÈ nicke et al., 1998a,b) .
In contrast to the anticancer drugs, we observed a dramatic dierence in apoptosis sensitivity when HeLa and MCF-7 cells were exposed to IR. A single dose of 20 Gy caused the death of 75% HeLa cells after 3 days, whereas the same treatment resulted in only marginal killing of MCF-7 cells (Figure 1c ). Cell death measurement by the dye exclusion test con®rmed these results (data not shown). Various radiation doses ranging from 1 to 10 Gy resulted in the dose-dependent death of HeLa cells which was partially inhibitable by zVAD-fmk, but did not alter the resistance of MCF-7 cells to IR (Figure 1d ). Together, these data suggest that the radiation-resistant phenotype of MCF-7 cells might be caused, at least in part, by the lack of caspase-3.
Anticancer drugs and IR induce the caspase-3-dependent events of DNA fragmentation and a-fodrin cleavage in HeLa, but not in caspase-3-deficient MCF-7 cells Caspase-3 is activated by various death stimuli including DNA-damaging agents (Dubrez et al., 1996; Fuchs et al., 1997; Simizu et al., 1998) . To investigate whether caspase-3 is activated in HeLa cells undergoing DNA damage-induced apoptosis, Western blot analyses were performed. A consistent decrease in procaspase-3 (indicative of the cleavage activation of caspase-3) was not detectable in etoposide-or doxorubicin-treated or irradiated HeLa cells (Figure 2a, upper panel) , which may be due to the upregulation of the casp-3 gene induced by DNA-damaging agents and the de novo synthesis of pro-caspase-3 (Droin et al., 1998) . Nevertheless, all these DNA-damaging agents gave rise to active caspase-3 fragments as judged by Western blotting (Figure 2b ) and by the DEVD-speci®c uorogenic substrate assay ( Figure 2c ). As caspase-3 is required for DNA fragmentation and cleavage of afodrin in TNF-or staurosporine-induced apoptosis of MCF-7 cells (JaÈ nicke et al., 1998a,b), we examined whether caspase-3 is also required for the induction of these events in apoptosis induced by DNA-damaging agents. FACS analysis con®rmed that apoptosis of HeLa cells induced by etoposide, doxorubicin, or IR correlated well with extensive DNA fragmentation as shown by the time-dependent increase in the apoptotic sub-G1 peak in treated cells (Figure 2d ). Using conventional agarose gel electrophoresis, the typical apoptotic DNA laddering was observed when HeLa cells were exposed to etoposide, doxorubicin or IR (data not shown). In addition, all these treatments resulted in the ecient caspase-3-dependent cleavage of a-fodrin into the typical 120 kDa fragment in these cells (Figure 2a , lower panel). Together, these results demonstrate that caspase-3 is processed and fully functional in HeLa cells treated with DNA-damaging agents.
Unlike in HeLa cells, a-fodrin was not cleaved into the 120 kDa fragment when caspase-3-de®cient MCF-7 cells were exposed to anti-cancer drugs or IR ( Figure  3a) . Moreover, neither DEVD activity (Figure 3b ) nor DNA fragmentation (Figure 3c and data not shown) were detectable in response to these treatments. Hence, our results indicate that, like apoptosis induced by TNF or staurosporine (JaÈ nicke et al., 1998a,b) , these events are also not required for the anticancer druginduced apoptotic death of MCF-7 cells. However, the caspase substrate poly(ADP-ribose)polymerase (PARP) was eciently cleaved following treatment of MCF-7 cells with etoposide or doxorubicin, but not when the cells were exposed to IR (Figure 3d ). Drug-induced cell death (data not shown) and PARP cleavage ( Figure  3d ) were blocked by zVAD-fmk, demonstrating that caspase-3-de®cient MCF-7 cells die by apoptosis, although some of the classic apoptotic hallmarks are missing.
Caspase-3 expression in MCF-7 cells restores a-fodrin cleavage and DNA fragmentation in response to the anticancer drugs, but not to IR As HeLa cells, unlike MCF-7 cells, are susceptible to IR-induced killing and undergo classical alterations of apoptosis, we next examined whether the lack of caspase-3 is responsible for the radiation-resistant phenotype of MCF-7 cells. For this purpose, MCF-7 cells stably expressing caspase-3 (clone MCF-7.3.28; JaÈ nicke et al., 1998b) were analysed for their sensitivity to DNA-damaging agents. As judged by crystal violet staining (Figure 4a ), trypan blue or propidium iodide uptake (data not shown), re-expression of caspase-3 did not signi®cantly enhance the sensitivity of MCF-7 cells to drug treatment. Surprisingly, expression of caspase-3 had also no eect on the susceptibility to IR treatment as MCF-7/casp-3 cells remained as radiation-resistant as parental MCF-7 cells. In agreement with these results, microscopic examination revealed that only HeLa cells exposed to IR, but not similarly treated MCF-7 or MCF-7/casp-3 cells displayed the typical apoptotic morphology (data not shown).
Similar to the results obtained with HeLa cells (Figure 2) , etoposide-or doxorubicin-induced apoptosis of MCF-7/casp-3 cells resulted in the generation of active caspase-3 fragments as shown by Western blotting (Figure 4b , lower panel) and by the DEVDspeci®c¯uorogenic substrate assay (Figure 4c ). In addition, cancer drug-induced caspase-3 activation resulted in cleavage of a-fodrin into the typical 120 kDa fragment (Figure 4b, upper panel) , and in DNA fragmentation as evidenced by the appearance of the apoptotic sub G1 peak in FACS analyses ( Figure  4d ) and by agarose gel electrophoresis (data not shown). These results clearly demonstrate that caspase-3 is also required for these events in anticancer drug-induced apoptosis. In contrast, exposure of the Figure 4d and data not shown). These results were similar to those obtained with irradiated parental MCF-7 cells (Figure 3) . Together, our data demonstrate that the pathway to caspase-3 activation is fully functional in MCF-7/casp-3 cells treated with etoposide or doxorubicin, but is not triggered when the cells are exposed to IR.
Anticancer drugs, but not IR induce cytochrome c release and caspase-9 activation in casp-3-transformed MCF-7 cells
Although the exact mechanism of apoptosis induced by DNA-damaging agents is presently unknown, the release of cytochrome c from mitochondria and subsequent activation of caspase-9 and caspase-3 appear to be essential Kuida et al., 1998; Chen et al., 2000) . To determine in more detail the reason for the inability of IR to activate caspase-3 in MCF-7/casp-3 cells, we monitored the release of cytochrome c from mitochondria. In HeLa cells cytosolic cytochrome c levels were greatly enhanced after exposure to etoposide, doxorubicin or IR (Figure 5a ). In addition, pro-caspase-9 processing was detected in HeLa cells exposed to all these DNAdamaging agents (data not shown) which is in agreement with the ecient activation of caspase-3 (Figure 2 ). In MCF-7/casp-3 cells, however, only the anticancer drugs etoposide or doxorubicin, but not IR induced cytochrome c release ( Figure 5b ) and procaspase-9 processing (Figure 5c ). Taken together, our data demonstrate that the intrinsic death pathway induced by anticancer drugs is fully functional in MCF-7/casp-3 cells, in contrast to the death pathway induced by IR, which appears to be defective in these cells presumably at a point upstream of mitochondrial cytochrome c release.
IR-induced DNA double-strand breaks result in G2/M arrest of the MCF-7 cell lines
The initial event following exposure to IR is the generation of DNA double-strand breaks (Wang, 1998) . To analyse whether DNA double-strand breaks are generated in MCF-7 cells following exposure to IR, the neutral single-cell gel electrophoresis system (comet assay) was employed. As shown in Figure 6a , IR induced signi®cant DNA double-strand breaks in all cell lines including the two radiation-resistant MCF-7 lines. In addition, these DNA double-strand breaks decreased to the same extent and with similar kinetics in all three cell lines indicating no dierences in the availability and functionality of the DNA repair machinery between these cells.
Although the IR-induced DNA double-strand breaks did not induce the intrinsic death pathway in MCF-7 or MCF-7/casp-3 cells, the possibility remained that these cells die via the necrotic pathway. Therefore we analysed the release of cytosolic lactate dehydrogenase (LDH), another measurement for cell death, into the supernatant from irradiated cells. As shown in Figure  6b , LDH activity was only detected in supernatants of IR-treated HeLa cells, but not in supernatants of similar treated MCF-7 or MCF-7/casp-3 cells. These results are in agreement with the data obtained using several other methods of cell death detection including crystal violet (Figures 1 and 4a) , DNA fragmentation (Figures 3c and 4d) , trypan blue exclusion, or propidium iodide uptake (Figure 1 and data not shown), thus con®rming the radiation-resistant phenotype of MCF-7 and MCF-7/casp-3 cells.
Cells exposed to IR arrest in various phases of the cell cycle in order to repair damaged DNA. Depending on the extent of the damage, cells either enter mitosis or die via apoptosis. Our previous experiments indicated that, in contrast to radiation-sensitive HeLa cells (Figure 2d ), radiation-resistant MCF-7 cells (Figure 3c ) and MCF-7/casp-3 cells (Figure 4d ) remained in G2/M following exposure to IR. To examine these dierences in more detail, we determined the percentages of cells in each phase of the cell cycle for a period of up to 4 days following IR treatment. In agreement with our previous data, we found that only HeLa cells succumb to apoptosis 2 days post IR with a prior accumulation in G2/M at day 1 (Figure 6c ). In contrast, MCF-7/casp-3 cells accumulated and remained in G2/M over the 4-day period, and no apoptotic cells were detected (Figure 6d) . Similar results were obtained with the parental MCF-7 cells (Figure 3c and data not shown) indicating that this event might be the reason for the failure of IR to activate the intrinsic death pathway in MCF-7 breast carcinoma cells.
Discussion
Chemotherapy and radiation are important treatment modalities for many cancers, but the frequent occurrence of drug-and radiation-resistant tumors is a common clinical problem. Many dierent mechanisms can account for poor patient prognosis and treatment failure including the loss or mutation of pro-apoptotic genes that regulate the intrinsic death pathway such as p53 or Apaf-1 (Lowe et al., 1993; Schmitt and Lowe, 1999; Soengas et al., 1999 Soengas et al., , 2001 ). Several investigators have also proposed a crucial role for caspase-3 in DNA damage-induced apoptosis, as in various tumor cells this protease is frequently activated during apoptosis induced by anticancer drugs and ionizing radiation ± 7) , or in cells exposed to IR, followed by incubation with medium for the indicated number of days (lanes 8 ± 10). One representative experiment of three is shown. (b) Eect on caspase-3-like activity. Cell lysates of MCF-7 cells treated for the indicated times with etoposide (squares), doxorubicin (triangles) or IR (circles) were incubated with the¯uorogenic susbstrate DEVD-Amc. The catalytic activities are given in arbitrary units (AU). DEVDase activity of untreated MCF-7 cells was 320 AU. (c) FACS analysis of MCF-7 cells either left untreated (control) or treated for the indicated number of days (d) with etoposide (100 mM) or doxorubicin (1 mg/ml) or exposed to 20 Gy followed by incubation with growth medium. The various cell cycle phases are indicated. One representative experiment of three is shown. (d) Western blot analysis of PARP cleavage in MCF-7 cells. Cells were either left untreated (lane 1), or were exposed for the indicated times to etoposide (lanes 2 ± 4), doxorubicin (lanes 5 ± 7) or IR (lanes 8 ± 10) in the absence (lanes 1 ± 3, 5 ± 6, 8 ± 9) or presence (lanes 4, 7 and 10) of zVAD-fmk (50 mM) (Dubrez et al., 1996; Fuchs et al., 1997; Martins et al., 1997; Yu and Little, 1998; Datta et al., 1997) . As the initiation of caspase-3-dependent DNA fragmentation and cleavage of several death substrates will surely lead to cell death, it was reasonable to speculate that the functional deletion of the casp-3 gene may be one important event leading to apoptosis resistance and to tumorigenesis (JaÈ nicke et al., 1998b) . However, based on our present and previous studies, MCF-7 cells can be killed via apoptosis by a variety of apoptotic stimuli including anticancer drugs in the absence of caspase-3 (JaÈ nicke et al., 1998a,b; Li et al., 1997a) . Together with the fact that a de®ciency of caspase-3 has not been reported for primary tumors, our results suggest that Figure 4 Re-expression of caspase-3 does not alter susceptibility of MCF-7/casp-3 cells to DNA-damaging agents. (a) Cytotoxicity assays of MCF-7 cells (open circles) and MCF-7/casp-3 cells (®lled circles) treated for the indicated times with etoposide or doxorubicin or exposed to IR followed by incubation with growth medium. Cell death was assessed using the crystal violet assay as described (JaÈ nicke et al., 1994) . Similar results were obtained when cell death was assessed by trypan blue uptake (data not shown). The values are derived from one representative experiment of three performed in triplicates. (b) Western blot analysis of the status of a-fodrin (upper panel), pro-caspase-3 (middle panel) and active caspase-3 (lower panel) in MCF-7/casp-3 cells is shown. Cells were either left untreated (lane 1), treated with etoposide (lanes 2 ± 4), or doxorubicin (lanes 5 ± 7), or were exposed to IR followed by incubation with growth medium for the indicated number of days (lanes 8 ± 10). One representative experiment of four is shown. (c) Eect on caspase-3-like activity. Cell lysates of MCF-7/casp-3 cells treated for 1 ± 3 days with etoposide (squares), doxorubicin (triangles), or exposed to IR (circles) followed by incubation with growth medium for 1 ± 3 days were incubated with the¯uorogenic substrate DEVD-Amc. The catalytic activities are given in arbitrary units (AU). DEVDase activity of untreated MCF-7/casp-3 cells was 430 AU. (d) FACS analysis of MCF-7/casp-3 cells treated as in b. The various cell cycle phases and the apoptotic sub-G1 peak are indicated. One representative experiment of ®ve is shown the lack of caspase-3 by itself may not be the major cause for the frequent occurrence of chemoresistant tumor cells.
Here we made the observation that in contrast to the anticancer drugs etoposide and doxorubicin, IR fails to induce the apoptotic death of MCF-7 cells. It has been reported that formation of free radicals might manipulate cell death pathways, diverting the cell's response to a noxious stimulus from apoptosis toward necrosis (Lee and Shacter, 1999) . However, using several dierent techniques for the detection of apoptotic or necrotic cell death including DNA fragmentation, caspase activation, a dye exclusion assay, crystal violet assay, propidium iodide uptake, MTT assay and LDH release, we could not detect any signi®cant death of IR-treated MCF-7 or MCF-7/casp-3 cells, clearly demonstrating the IR resistance of these cells. According to our present data, the radiation-resistant phenotype of MCF-7 cells can be readily explained by the failure of IR to trigger the intrinsic death pathway in these cells upstream of cytochrome c release and the activation of caspases-9 and -3. As cytochrome c is released and caspases-9 and -3 are activated in IR-treated HeLa cells (this study) and several other cell types (Fuchs et al., 1997; Yu and Little, 1998; Datta et al., 1997) , our results suggest that the apoptotic death pathway induced by IR is defective in MCF-7 cells upstream of mitochondrial cytochrome c release.
Agents known to induce apoptosis via the intrinsic death pathway such as the anticancer drugs etoposide and doxorubicin or the protein kinase inhibitor staurosporine eciently kill MCF-7/casp-3 cells via the intrinsic death pathway resulting in cytochrome c release and activation of caspases -9 and -3 (JaÈ nicke et al., 1998b; Engels et al., 2000; this study). Even caspase-3-de®cient MCF-7 cells undergo caspase-dependent apoptosis following treatment with etoposide or doxorubicin as both, cell death and PARP cleavage could be blocked by zVAD-fmk. Thus, MCF-7 cells do not exhibit a general defect in the intrinsic apoptotic pathway. Our results rather suggest that anticancer drugs and IR utilize dierent signaling pathways upstream of mitochondrial cytochrome c release. It seems surprising that two classes of DNA-damaging agents that are known to induce apoptosis via DNA double-strand breaks should not utilize the same death pathway upstream of mitochondria. In support of our conclusion, however, are several reports demonstrating that, in contrast to the frequent occurrence of crossresistance between various anti-cancer drugs, crossresistance between cytotoxic drugs and ionizing radiation is relatively rare (Lehnert et al., 1989; Oshita et al., 1992; Heenan et al., 1996) .
What are the components involved in the radiationresistant phenotype of MCF-7 cells? The release of cytochrome c is regulated by pro-and anti-apoptotic members of the Bcl-2 family such as Bax and Bcl-X L , respectively, and the deregulated expression of these proteins is known to result in aberrant apoptotic responses (Vander Heiden and Thompson, 1999) . However, no signi®cant dierences in the constitutive and DNA damage-inducible expression levels of these proteins were observed in MCF-7 cells compared to HeLa cells (data not shown). Alternatively, IR might induce an extremely ecient DNA repair system in MCF-7 cells, thus preventing the generation of an apoptotic signal. Our data obtained with the comet assay, however, argue against this possibility, as the DNA double-strand breaks that are induced by IR to the same extent in HeLa and in MCF-7 cells are also repaired with similar eciencies in both cell lines.
Might the G2/M cell cycle arrest observed only in MCF-7 cells but not in HeLa cells provide a clue to the mechanism of IR resistance in MCF-7 cells? In contrast to HeLa cells, MCF-7 cells express a functional p53 gene. p53 plays a pivotal role in regulating a checkpoint in the G1 phase of the cell cycle, and it is also required for IR-induced G2/M arrest (Bunz et al., 1998; Sionov and Haupt, 1999 ). Western blot analysis of caspase-9 in MCF-7/casp-3 cells. Cells were either left untreated or treated for the indicated number of days with etoposide or doxorubicin, or exposed to IR followed by incubation with growth medium. Pro-caspase-9 and cleaved caspase-9 are indicated Oncogene Radiation-induced G2/M arrest but not apoptosis in MCF-7 cells RU Ja Ènicke et al Whereas the cyclin-dependent kinase inhibitor p21/ waf1/cip1 contributes to both G1 and G2/M arrest following radiation treatment, the p53-dependent induction of 14-3-3 sigma and GADD45 selectively mediate the G2/M arrest via interference with a pathway that is controlled by the ATM and chk kinases (Sionov and Haupt, 1999) . Our ®nding that irradiated MCF-7 cells (but not HeLa cells) arrest preferentially in G2/M is remarkable, because it indicates that there is a selective defect in the p53-dependent G2/M but not G1 checkpoint in these cells. We propose that the preferential G2/M arrest in irradiated MCF-7 cells prevents the generation of an as yet unknown apoptotic signal required for the activation of the intrinsic death pathway.
In conclusion, our results demonstrate that caspase-3, although not essential for the process of apoptosis itself, is required for cancer drug-induced DNA fragmentation and a-fodrin cleavage in MCF-7 cells.
Caspase-3 has now been shown to be indispensable for these hallmarks of apoptosis induced by numerous death stimuli and in every cell type examined (JaÈ nicke et al., 1998a,b; Woo et al., 1998; Zheng et al., 1998; Porter and JaÈ nicke, 1999; Kuida et al., 1996) . As IR fails to induce the mitochondrial death pathway, including activation of caspase-3 in MCF-7/casp-3 cells, the question of whether caspase-3 contributes to IR-induced apoptosis cannot be properly answered yet. However, our results suggest that the radiationresistant phenotype of MCF-7 breast carcinoma cells is not caused by the functional deletion of the casp-3 gene or any other gene of the intrinsic death pathway, but may be due to the IR-induced G2/M arrest that prevents the generation of an apoptotic signal required for the activation of this pathway. Our results also indicate the requirement of dierent initiating events for apoptosis pathways induced by either drug treatment or radiation. 
Materials and methods
Cell lines, reagents and antibodies
HeLa H21 cervical carcinoma cells (JaÈ nicke et al., 1994) , MCF-7 breast carcinoma cells and MCF-7/casp-3 cells stably expressing caspase-3 (JaÈ nicke et al., 1998a,b) were maintained in RPMI 1640, supplemented with 10% FCS, 10 mM glutamine, and 50 mg (each) of streptomycin and penicillin/ ml. The protease inhibitors aprotinin, bacitracin, antipain, leupeptin and phenylmethylsulfonyl¯uoride as well as etoposide and doxorubicin were purchased from Sigma. The broad range caspase inhibitor zVAD-fmk was purchased from Enzyme Systems (Dublin, CA, USA). The monoclonal antibodies to pro-caspase-3 and active caspase-3 were from Transduction Laboratories and from R&D Systems, respectively. A polyclonal antibody to caspase-9 was purchased from New England BioLabs, Inc., and the monoclonal cytochrome c and PARP antibodies were from Pharmingen, Inc. The monoclonal anti-a-fodrin antibody (mAb1622) was from Chemicon International.
Preparation of cell extracts and Western blotting
Cell extracts were prepared as described (JaÈ nicke et al., 1996) . To con®rm equal loadings, protein concentrations were determined with the Bio-Rad protein assay. Proteins were separated in SDS-polyacrylamide gels, and subjected to Western blotting. The proteins were visualized with the Amersham ECL kit.
Measurements of cell death
Cells were treated with etoposide (100 mM), doxorubicin (1 mg/ml) or were exposed to IR (usually 20 Gy) using a gamma chamber 4000 A (Bhabha Atomic Research Centre, Trombay, Bombay, India). Cell death was assessed by various methods including microscopic examination, trypan blue uptake, or with the standard cytotoxicity assay (crystal violet assay) which is a measurement of cell viability (JaÈ nicke et al., 1994) . The release of lactate dehydrogenase (LDH) into the supernatant of irradiated cells (Vassault, 1983) was employed as another measurement of cell death. LDH activity was assessed according to the protocol of the manufacturer (Roche Molecular Biochemicals). Cell death was also assessed by the uptake of propidium iodide (2 mg/ ml, Sigma) into non®xed cells and subsequent¯ow cytometric analyses with the FSC/FL2 pro®le (Wesselborg et al., 1999) .
DNA fragmentation and cell cycle analyses
Due to the requirement of caspase-3 for DNA fragmentation (JaÈ nicke et al., 1998b; this study), the method of Nicoletti (Nicoletti et al., 1991) to measure the leakage of fragmented DNA from apoptotic nuclei could only be assessed in caspase-3-expressing cells (HeLa H21 and MCF-7/casp-3), but not in caspase-3-de®cient MCF-7 cells. Brie¯y, apoptotic nuclei were prepared by lysing cells in a hypotonic lysis buer (0.1% sodium citrate, 0.1% Triton X-100 and 50 mg/ml propidium iodide) and subsequently analysed by¯ow cytometry. Nuclei to the left of the G1 peak containing hypodiploid DNA were considered as apoptotic. For cell cycle analyses, cells were ®xed in ice-cold 80% ethanol, washed with PBS and stained with propidium iodide (50 mg/ ml, Sigma) at 378C for 60 min in the presence of ribonuclease (20 mg/ml, Sigma) and 0.1% Triton X-100. All¯ow cytometry analyses were performed on a FACScalibur (Becton Dickinson) by using CellQuest analysis software. For each determination, a minimum of 20 000 cells was analysed.
Fluorimetric determination of caspase-3 activity
Caspase-3 activity was determined by incubation of cell lysates with 50 mM of the¯uorogenic substrate DEVD-AMC (Nacetyl-Asp-Glu-Val-Asp-aminomethylcoumarin; Bachem, Heidelberg, Germany) in 200 ml buer containing 50 mM HEPES pH 7.4, 100 mM NaCl, 10% sucrose, 0.1% CHAPS and 10 mM dithiothreitol. The release of aminomethylcoumarin was measured by¯uorometry using an excitation wavelength of 360 nm and an emission wavelength of 475 nm.
Neutral single cell gel electrophoresis (comet assay)
The procedure originally described for the detection of DNA double-strand breaks on an individual cell level (Klaude et al., 1996) was modi®ed as follows. Cells were trypsinized and washed twice with PBS. Ten ml of the cell suspension (1610 6 / ml) was resuspended in 120 ml 0.5% low melting point agarose, spotted onto a microscope slide and covered with a coverslide. After removal of the coverslide, cells were incubated for 1 h at 48C in neutral lysis buer (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 1% sodium laurylsarcosinate (pH 7.5). Electrophoresis was carried out at 48C for 15 min in 90 mM Tris, 90 mM boric acid, and 2 mM EDTA. The ethanol-®xed and ethidium bromide-stained slides were analysed with a¯uorescence microscope. Analysis of DNA migration was performed using an image analysis system (Kinetic Imaging Ltd., Komet 4.0.2; Optilas) determining the median tail moment (percentage of DNA in the tail6tail length) of 50 cells per sample.
Measurement of cytochrome c release
For analysis of cytochrome c release, approximately 4610 6 cells were resuspended in 200 ml of buer A containing 250 mM sucrose, 20 mM HEPES pH 7.4, 1.5 mM Mg Cl 2 , 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM phenylmethylsulfonyl¯uoride, and 10 mg/ml of each of the protease inhibitors aprotinin, bacitracin, antipain, leupeptin. Cells were homogenized, and the homogenates were centrifuged at 1000 g for 10 min at 48C to remove cell nuclei. The supernatants were transferred to a fresh tube and centrifuged at 10 000 g for 10 min at 48C to deplete mitochondria. The resulting supernatants were loaded on a 0.1% SDS and 15% polyacrylamide gel. Cytochrome c release was analysed by immunoblotting with the mouse monoclonal antibody 7H8.2Cl2 (Pharmingen, Inc.). Abbreviations TNF, tumor necrosis factor; IR, ionizing radiation; zVADfmk, benzyloxycarbonyl-Val-Ala-Asp-¯uoromethylketone; PARP, poly(ADP-ribose)polymerase; DEVD-amc, N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin
